These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 19033482)

  • 1. Discordant results from "real-world" patient samples assayed for digoxin.
    Jones TE; Morris RG
    Ann Pharmacother; 2008 Dec; 42(12):1797-803. PubMed ID: 19033482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suspected DLIS interference in the dimension DGNA digoxin assay method and the clinical application of the revised digoxin target range.
    Morris RG; Jones TE; Goldsworthy SJ; Wagner TJ; Ho H; Horowitz JD
    Ther Drug Monit; 2006 Jun; 28(3):454-7. PubMed ID: 16778733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the specificity of digoxin immunoassays.
    Valdes R
    Wien Klin Wochenschr Suppl; 1992; 191():55-9. PubMed ID: 1509756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical repercussions of analytical interferences due to aldosterone antagonists in digoxin immunoassays: an assessment.
    Cobo A; Martín-Suarez A; Calvo MV; Domínguez-Gil A; de Gatta MM
    Ther Drug Monit; 2010 Apr; 32(2):169-76. PubMed ID: 20216123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Digoxin-like immunoreactivity in newborn infants--a pitfall of digoxin therapy?].
    Heise HR; Vorwerk P; Fritsche K; Richter R
    Kinderarztl Prax; 1993 May; 61(3):108-11. PubMed ID: 8326698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous digoxin-like immunoreactive factors (DLIF) as measured by the CEDIA digoxin assay and a fluorescence polarization immunoassay.
    Schlebusch H; Jarausch J; Domke I
    Wien Klin Wochenschr Suppl; 1992; 191():59-66. PubMed ID: 1509757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous and exogenous digoxin-like immunoreactive substances: impact on therapeutic drug monitoring of digoxin.
    Dasgupta A
    Am J Clin Pathol; 2002 Jul; 118(1):132-40. PubMed ID: 12109847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interference of digoxin like immunoreactive substances with four recent reagents for digoxin determination].
    Marzullo C; Bourderont D; Dorr R
    Ann Biol Clin (Paris); 1996; 54(2):91-6. PubMed ID: 8763633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lasofoxifene on the pharmacokinetics of digoxin in healthy postmenopausal women.
    Roman D; Bramson C; Ouellet D; Randinitis E; Gardner M
    J Clin Pharmacol; 2005 Dec; 45(12):1407-12. PubMed ID: 16291716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interference of digoxin-like immunoreactive substances with three digoxin immunoassays in patients with various degrees of renal function.
    Pleasants RA; Gadsden RH; McCormack JP; Piveral K; Sawyer WT
    Clin Pharm; 1986 Oct; 5(10):810-6. PubMed ID: 3780148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of the multicenter evaluation of a novel homogeneous immunoassay for digoxin based on the cloned enzyme donor immunoassay technology.
    Jarausch J; Collinsworth W; Cano Y; Hafner G; Hammer E; Malandain H; Pokieser L; Redondo FL; Schlebusch H; Taylor A
    Wien Klin Wochenschr Suppl; 1992; 191():69-73. PubMed ID: 1509759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of digoxin-like immunoreactive substances in sera of 15 elder patients with cardiac insufficiency].
    Li J; Wu Z; Xu J; Zhou Y; Chu X
    Yao Xue Xue Bao; 1998 Sep; 33(9):655-8. PubMed ID: 12016868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of interferences including metabolite crossreactivity on therapeutic drug monitoring results.
    Dasgupta A
    Ther Drug Monit; 2012 Oct; 34(5):496-506. PubMed ID: 22846896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring the unbound concentration fails to resolve analytic interferences in digoxin immunoassays.
    Morris RG; Jones TE; Wicks FA; Rogers NM
    Ther Drug Monit; 2008 Aug; 30(4):548-52. PubMed ID: 18641559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digoxin: clinical highlights: a review of digoxin and its use in contemporary medicine.
    Ehle M; Patel C; Giugliano RP
    Crit Pathw Cardiol; 2011 Jun; 10(2):93-8. PubMed ID: 21988950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetic investigation of digoxin in Japanese neonates.
    Yukawa E; Akiyama K; Suematsu F; Yukawa M; Minemoto M
    J Clin Pharm Ther; 2007 Aug; 32(4):381-6. PubMed ID: 17635340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the CEDIA digoxin assay on Boehringer Mannheim/Hitachi 717 analyzer.
    Redondo FL
    Wien Klin Wochenschr Suppl; 1992; 191():66-8. PubMed ID: 1509758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring endogenous digoxin-like substance and exogenous digoxin in the serum of low-birth-weight infants.
    Ng PK; LeGatt D; Coates J; Collins-Nakai RL
    Am J Hosp Pharm; 1985 Sep; 42(9):1977-9. PubMed ID: 3901741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic drug monitoring of digoxin: impact of endogenous and exogenous digoxin-like immunoreactive substances.
    Dasgupta A
    Toxicol Rev; 2006; 25(4):273-81. PubMed ID: 17288498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Digoxin].
    Yamamoto K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():403-5. PubMed ID: 15658349
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.